Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8471333rdf:typepubmed:Citationlld:pubmed
pubmed-article:8471333lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:8471333lifeskim:mentionsumls-concept:C1151722lld:lifeskim
pubmed-article:8471333pubmed:issue5lld:pubmed
pubmed-article:8471333pubmed:dateCreated1993-5-18lld:pubmed
pubmed-article:8471333pubmed:abstractTextDihydropyrimidine dehydrogenase (DPD) is the major catabolic enzyme of pyrimidines and fluoropyrimidines. The clinical course of 2 patients with suspected DPD deficiency is described. Both patients had significantly delayed clearance of fluorouracil (5-FU), elevated plasma uracil concentrations, and subsequent lethal toxicity. The prevalence of DPD deficiency in the general population is unknown, but given the large number of cancer patients treated with 5-FU, it may be of great clinical significance. Lymphocytes have been previously shown to be a useful marker of systemic DPD activity. Because DPD activity has not been previously reported in a large population of cancer patients using 5-FU as the substrate, we determined DPD activity in lymphocytes from 66 patients with cancer. DPD activity was determined by a sensitive high performance liquid chromatography method. The mean DPD activity (S.D.) in 66 patients with head and neck cancer was 0.189 (0.071) nomol/min/mg protein with wide interpatient variability (range 0.058-0.357). DPD activity was not correlated to age (r = -0.164, P = 0.188). The mean DPD activity in men [0.192 (0.074)] was not significantly different from that in women [0.172 (0.057); t-test P = 0.418]. Likewise, there was no statistical difference in DPD activity in patients who had not received prior chemotherapy [0.195 (0.066)] to patients receiving one or more cycles of chemotherapy [0.186 (0.074); t-test P = 0.638].lld:pubmed
pubmed-article:8471333pubmed:languageenglld:pubmed
pubmed-article:8471333pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471333pubmed:citationSubsetIMlld:pubmed
pubmed-article:8471333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471333pubmed:statusMEDLINElld:pubmed
pubmed-article:8471333pubmed:issn0959-8049lld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:SchneiderMMlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:DemardFFlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:PlagneRRlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:FlemingR ARAlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:ThyssAAlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:SEGALM LMLlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:GaspardM HMHlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:MilanoG AGAlld:pubmed
pubmed-article:8471333pubmed:authorpubmed-author:BargnouxP JPJlld:pubmed
pubmed-article:8471333pubmed:issnTypePrintlld:pubmed
pubmed-article:8471333pubmed:volume29Alld:pubmed
pubmed-article:8471333pubmed:ownerNLMlld:pubmed
pubmed-article:8471333pubmed:authorsCompleteYlld:pubmed
pubmed-article:8471333pubmed:pagination740-4lld:pubmed
pubmed-article:8471333pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:meshHeadingpubmed-meshheading:8471333-...lld:pubmed
pubmed-article:8471333pubmed:year1993lld:pubmed
pubmed-article:8471333pubmed:articleTitleDihydropyrimidine dehydrogenase activity in cancer patients.lld:pubmed
pubmed-article:8471333pubmed:affiliationLaboratoire d'Oncopharmacologie, Centre Antoine Lacassagne, Nice, France.lld:pubmed
pubmed-article:8471333pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8471333pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8471333pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8471333lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8471333lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8471333lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8471333lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8471333lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8471333lld:pubmed